| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. | JAMA | 2009 | 6.80 |
| 2 | The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study. | Am Heart J | 2008 | 2.61 |
| 3 | Association of single nucleotide polymorphisms on chromosome 9p21.3 with platelet reactivity: a potential mechanism for increased vascular disease. | Circ Cardiovasc Genet | 2010 | 1.64 |
| 4 | Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes. | Circ Cardiovasc Genet | 2013 | 0.99 |
| 5 | Aspirin Resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study). | Am J Cardiol | 2009 | 0.97 |
| 6 | Assessment of contemporary stent deployment using intravascular ultrasound. | Catheter Cardiovasc Interv | 2002 | 0.77 |